Kura Oncology (KURA) Other Non-Current Liabilities (2014 - 2026)

Kura Oncology (KURA) has 13 years of Other Non-Current Liabilities data on file, last reported at $3.4 million in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 60.68% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 60.68% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 76.32% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $3.4 million, up from $3.2 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for KURA reached as high as $3.4 million in Q1 2026 and fell as low as $265000.0 in Q4 2022.
• Historically, Other Non-Current Liabilities has averaged $1.4 million across 5 years, with a median of $951000.0 in 2024.
• Across the five-year window, Other Non-Current Liabilities fell 29.33% in 2022 and surged 170.94% in 2024, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $265000.0 in 2022, then soared by 166.04% to $705000.0 in 2023, then soared by 154.61% to $1.8 million in 2024, then jumped by 76.32% to $3.2 million in 2025, then rose by 8.59% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $3.4 million in Q1 2026, $3.2 million in Q4 2025, and $3.0 million in Q3 2025.